Bridge Biotherapeutics, Inc. (KOSDAQ: 288330)
South Korea
· Delayed Price · Currency is KRW 4,060.00
-540.00 (-11.74%)
Dec 19, 2024, 3:00 PM KST
Bridge Biotherapeutics Revenue
Bridge Biotherapeutics had revenue of 1.08M KRW in the quarter ending September 30, 2024, a decrease of -317,747.06%. This brings the company's revenue in the last twelve months to 1.08M, down -99.95% year-over-year. In the year 2023, Bridge Biotherapeutics had annual revenue of 100.00M, down -96.69%.
Revenue (ttm)
1.08M
Revenue Growth
-99.95%
P/S Ratio
n/a
Revenue / Employee
30.86K
Employees
35
Market Cap
170.61B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition